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Biologically relevant functionalised N-[4-(2-oxoazetidin-1-yl)-but-1-enyl]acetamides have been 
prepared in a two-step approach starting from N-(2-propenyl)-β-lactams, involving initial 
rhodium-catalysed hydroformylation followed by subjection of the obtained aldehydes to 
Staudinger reaction conditions. 
 
In the past decade, the catalytic hydroformylation of alkenes has acquired a prominent 
position in the field of homogeneous catalysis.
1
 The general interest in metal-catalysed 
hydroformylation reactions is due to their high atom efficiency and the availability of active 
and selective catalysts. In addition, the transformation of alkenes into aldehydes creates a 
significant added value, as the latter functional group represents an enormous synthetic 
potential towards the preparation of a variety of relevant target compounds. Nevertheless, the 
catalytic hydroformylation of alkenes is mainly considered as a valuable industrial process, 
and applications in the small-scale synthesis of fine chemicals
2
 are rather limited. However, in 
recent years, metal-catalysed hydroformylations have found their way towards useful 
applications in organic synthesis, for example for the construction of interesting oxa- and 
azaheterocycles.
3
 These examples illustrate the fact that the integration of catalytic 
hydroformylations in the design of novel organic syntheses constitutes an emerging area with 
promising prospects in terms of efficiency and selectivity. 
Within medicinal chemistry, the synthesis and transformation of β-lactams comprises an 
important field of research, as the class of β-lactam antibiotics is generally recognised as a 
cornerstone of human health care due to their unparalleled clinical efficacy and safety.
4
 
Furthermore, β-lactams have proven to be excellent substrates for further elaboration, which 
has led to the introduction of the term “β-lactam synthon method” in 1997.5,6  
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In the present report, the application of catalytic hydroformylation in the synthesis of 
functionalised β-lactams is disclosed, thus providing a useful example of the successful 
integration of homogeneous catalysis within β-lactam chemistry. In particular, the 
unprecedented rhodium-catalysed hydroformylation of N-(2-propenyl)-β-lactams is employed 
as a key step in the synthesis of functionalised N-[4-(2-oxoazetidin-1-yl)-but-1-
enyl]acetamides. The latter compounds  are of interest in the framework of anticancer 
research, 
, ,
 as the presence of an enamido moiety embedded in a larger molecular architecture 
constitutes a relevant pharmacophore in that respect. The interest in this type of compounds 
stems from the isolation of different natural products with pronounced antitumor activities, 
such as the marine lipopeptide Somocystinamide A
7
 and the macrolides Apicularen A, 
isolated from the myxobacterial genus Chondromyces,
8
 and lobatamide C, isolated from 
southwestern Pacific tunicates.
9
 All of these natural compounds accommodate an enamide 
functionality as an essential part of their structure. Apart from a few reports on the 
hydroformylation of 4-vinyl-β-lactams,10 the catalytic hydroformylation of β-lactams remains 
an unexplored field of research to date. 
 
Initially, a synthetic concept was devised based on the preparation of N-allyl-β-lactams, 
followed by metal-catalysed hydroformylation as a key step and finally subjection of the 
obtained aldehydes to classical Staudinger reaction conditions. 
Thus, N-(2-propenyl)- and N-(2-methyl-2-propenyl)imines 2 were synthesised via 
condensation of benzaldehydes 1 with allylamine or 2-methylallylamine in CH2Cl2 in the 
presence of MgSO4 (Scheme 1).
11
 In case of N-(2-methyl-2-propenyl)imines 2 (R
2
 = Me), the 
hydrochloride salt of 2-methylallylamine was used in the presence of Et3N. Subsequently, the 
obtained N-(arylmethylidene)amines 2 were used as such for the Staudinger synthesis of β-
lactams 3, affording cis-3-(alkoxy or phenoxy)-4-arylazetidin-2-ones
12
 3a-j in 81-90% yield 
upon treatment with methoxy-, phenoxy- or benzyloxyacetyl chloride in CH2Cl2 in the 
presence of Et3N (Scheme 1, Table 1). The observed cis-selectivity is in accordance with the 
known cis-selectivity associated to the use of Bose-Evans ketenes
13
 and could be deduced 
from the 
1
H NMR spectra of β-lactams 3, as the coupling constants between the protons at C3 
and C4 varied between 4.4 and 4.7 Hz (CDCl3).
14
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Table 1. Synthesis of β-lactams 3a-j. 
Entry R
1 
R
2 
R
3
 β-Lactam 3 (Yield) 
1 H H Ph 3a (89%) 
2 H H Me 3b (90%) 
3 H H Bn 3c (86%) 
4 4-Cl H Ph 3d (81%) 
5 2-Br H Bn 3e (85%) 
6 H Me Ph 3f (86%) 
7 H Me Me 3g (86%) 
8 H Me Bn 3h (89%) 
9 4-Cl Me Ph 3i (85%) 
10 2-Br Me Bn 3j (84%) 
 
 
As stated earlier, metal-catalysed hydroformylations comprise a powerful tool in organic 
synthesis. Up to now, this transformation has not been applied to (2-oxoazetidin-1-yl)-
substituted alkenes, although this approach would constitute a convenient alternative for the 
conventional synthesis involving the preparation of 1-(4-hydroxybutyl)-β-lactams (via alcohol 
protection/deprotection)
15
 and a final oxidation step. 
Consequently, N-(2-propenyl)-β-lactams 3 were evaluated as substrates for catalytic 
hydroformylation towards the corresponding aldehydes. At first, N-allyl-β-lactams 3a-e (R2 = 
H) were subjected to standard hydroformylation conditions, i.e. treatment with syngas (20 bar 
CO/H2, 1/1) using (acetylacetonato)dicarbonylrhodium(I) [Rh(acac)(CO)2] as a catalyst 
precursor (substrate/Rh = 500) and xantphos
16
 as a ligand (xantphos/Rh = 2) in toluene (cS = 
0.25 M) at 80°C (preformation: 1 h, reaction: 16 h). Gratifyingly, complete conversion of β-
lactams 3a-e occurred under the given reaction conditions as monitored by GC analysis using 
n-decane as an internal standard, furnishing a mixture of linear and branched aldehydes 4a-e 
(R
2
 = H) and 5a-e (R
2
 = H) in good yields (Scheme 2, Table 2). Spectroscopic analysis (
1
H 
NMR) of the reaction mixtures revealed the presence of linear N-(4-oxobutyl)azetidin-2-ones 
4 
4a-e as the major regioisomers (83-93%). In addition, a diastereomeric mixture of branched 
isomers 5a-e was formed as the minor regioisomers (7-17%, dr ~1/1). Attempts to improve 
the regioselectivity by increasing the xantphos/Rh ratio from 2 to 4 or 8 were not successful. 
The major isomers 4a-e were isolated in pure form through column chromatography on silica 
gel. 
 
Subsequently, N-(2-methyl-2-propenyl)-β-lactams 3f-j (R2 = Me) were studied as substrates 
for rhodium-catalysed hydroformylation. Initial attempts using triphenylphosphine as a ligand 
applying a range of reaction conditions (20 bar CO/H2, substrate/Rh = 500, PPh3/Rh = 20, 80-
120°C, 16-40 h) always led to partial conversion (12-71%). On the other hand, the use of 
tris(2,4-di-tert-butylphenyl)phosphite as a bulky -acceptor ligand expectedly led to full 
conversion of β-lactams 3f-j (R2 = Me) under the given reaction conditions (20 bar CO/H2 
(1/1), substrate/Rh = 1000, ligand/Rh = 10, toluene, cS = 0.25 M, preformation: 1 h, 100°C, 
reaction: 16 h, 100°C). As foreseen, only the corresponding linear aldehydes 4f-j (R
2
 = Me) 
were obtained in good yields (Scheme 2, Table 2), as 1,1-disubstituted alkenes are known to 
afford linear aldehydes in high regioselectivity upon hydroformylation according to 
Keulemans’ empirical rule.17 
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Table 2. Catalytic hydroformylation of N-(2-propenyl)azetidin-2-ones 3a-j. 
Entry Substrate R
1 
R
2
 R
3 
Ligand
a 
Conditions
b
 4, 5 (yield, ratio 4/5)
c,d
 
1 3a H H Ph xantphos A 4a, 5a (79%, 89/11) 
2 3b H H Me xantphos A 4b, 5b (89%, 88/12) 
3 3c H H Bn xantphos A 4c, 5c (86%, 93/7) 
4 3d 4-Cl H Ph xantphos A 4d, 5d (97%, 89/11) 
5 3e 2-Br H Bn xantphos A 4e, 5e (81%, 83/17) 
6 3f H Me Ph P(OR)3 B 4f, 5f (82%, > 99/1) 
7 3g H Me Me P(OR)3 B 4g, 5g (95%, > 99/1) 
8 3h H Me Bn P(OR)3 B 4h, 5h (92%, > 99/1) 
5 
9 3i 4-Cl Me Ph P(OR)3 B 4i, 5i (89%, > 99/1) 
10 3j 2-Br Me Bn P(OR)3 B 4j, 5j (77%, > 99/1) 
a
 Xantphos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; P(OR)3 = tris(2,4-di-tert-butyl-
phenyl)phosphite 
b
 A = 20 bar CO/H2 (1/1), Substrate/Rh = 500, Xantphos/Rh = 2, cS = 0.25 M, preformation: 1 h, 80°C, 
reaction: 16 h, 80°C; B = 20 bar CO/H2 (1/1), Substrate/Rh = 1000, P(OR)3/Rh = 10, cS = 0.25 M, 
preformation: 1 h, 100°C, reaction: 16 h, 100°C. 
c
 Yield of the mixtures of β-lactams 4 and 5 
d
 Ratio determined by 
1
H NMR analysis 
 
The relative cis-stereochemistry of the substituents attached to the β-lactam nucleus did not 
affect the diastereoselectivity during hydroformylation, as a 1/1 mixture of syn and anti 
isomers – concerning the position of the methyl group (R2 = Me) with respect to the β-lactam 
substituents at C3 and C4 – was obtained. Furthermore, it is worth mentioning that a Rh-
catalysed isomerisation of the double bond in N-(2-methyl-2-propenyl)-β-lactams towards N-
(2-methyl-1-propenyl)-β-lactams took place as well under the given reaction conditions, albeit 
to a limited extent (< 5%, 
1
H NMR). 
 
The introduction of an aldehyde functionality within β-lactams 4 creates a variety of synthetic 
opportunities for further elaboration such as alcohol synthesis, α-halogenation or α-alkylation, 
formation of imines and subsequent α-functionalisation or reduction. In light of the known 
reactivity of imines towards ketenes under Staudinger reaction conditions, our initial plan 
comprised imination of aldehydes 4, followed by [2+2]-cycloaddition with different Bose-
Evans ketenes to form novel bis-β-lactams. Whereas the condensation of aldehydes 4 with a 
variety of primary amines proceeded smoothly under standard imination conditions, 
subsequent reaction with methoxy-, phenoxy- or benzyloxyacetyl chloride in benzene in the 
presence of Et3N did not afford the contemplated bis-azetidin-2-ones. Nonetheless, full and 
selective substrate conversion occurred, furnishing novel products in good yields. Detailed 
spectroscopic analysis finally revealed the molecular structure of the latter products to be 
enamides 7, which can be explained considering the formation of intermediate iminium 
species 8, followed by α-deprotonation with respect to the iminium moiety (Scheme 3, Table 
3). It is known that N-(alkylmethylidene)amines are less reactive towards [2+2]-cycloaddition 
reactions as compared to N-(arylmethylidene)amines, sometimes resulting in the formation of 
enamides instead of azetidin-2-ones.
18
 The E-stereochemistry assigned to the carbon-carbon 
double bond in enamides 7 is supported by the observed vicinal coupling constants between 
both olefinic protons (J = 13.8 Hz, 
1
H NMR, CDCl3). It should be noted that in case of 
6 
enamides 7d-f (R
2
 = Me) only one diastereoisomer could be isolated in pure form after 
column chromatography on silica gel, hence the lower yields. 
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Table 3. Synthesis of 1-(4-iminobutyl)-β-lactams 6a-f and N-[4-(2-oxoazetidin-1-yl)-but-1-
enyl]acetamides 7a-f. 
Entry R
1 
R
2
 R
3 
R
4 
R
5 
Imine 6 (Yield)
 
Enamide 7 (Yield)
a
 
1 H H Ph Bn Me 6a (97%) 7a (59%) 
2 H H Bn iPr Ph 6b (92%) 7b (68%) 
3 4-Cl H Ph nPr Bn 6c (95%) 7c (63%) 
4 H Me Bn cHex Ph 6d (96%) 7d (35%) 
5 H Me Me Bn Ph 6e (93%) 7e (33%) 
6 4-Cl Me Ph iPr Bn 6f (98%) 7f (31%) 
a
 Yields after column chromatography on silica gel 
 
As described in the introduction, β-lactams 7 bearing an enamido moiety are of interest within 
the framework of anticancer research. Given the medicinal importance of functionalised 
azetidin-2-ones, the combination of the β-lactam entity with an enamido moiety might create 
new opportunities for the development of novel lead compounds. 
 
In conclusion, biologically relevant functionalised N-[4-(2-oxoazetidin-1-yl)-but-1-
enyl]acetamides have been prepared starting from N-(2-propenyl)-β-lactams in a two-step 
approach, involving (i) the unprecedented catalytic hydroformylation of the olefinic moiety in 
the latter β-lactams and (ii) treatment of the obtained aldehydes with alkoxyacetyl chlorides 
under Staudinger reaction conditions. 
7 
 
 
Experimental part 
Hydroformylation of N-(2-propenyl)-β-lactams 3a-j 
General procedure for the hydroformylation of N-(2-propenyl)-β-lactams 3a-e. In a typical 
experiment, a stainless steel standard autoclave was dried under vacuum at 100°C overnight 
and filled with argon. Afterwards, the autoclave was flushed 20 times with argon to remove 
oxygen traces and was charged with a solution of Rh(acac)(CO)2 (0.03 mmol) and xantphos 
(0.06 mmol) in degassed toluene (10 mL) under argon. The atmosphere was further 
exchanged with a 1:1 mixture of CO/H2 and the reactor was heated to 80°C and pressurised 
with CO/H2 to 20 bar. The catalyst was preformed at 20 bar (CO/H2) and 80°C for 1 h at 2000 
rpm (mechanical stirring). Subsequently, the substrate 3 (7.5 mmol), dissolved in degassed 
toluene (20 mL), was added from a dropping funnel, followed by hydroformylation at 20 bar 
(CO/H2) and 80°C for 16 h at 2000 rpm. The reaction was stopped by cooling the reactor to 
room temperature and venting. The catalyst was removed by filtration through neutral 
alumina, the solvent was evaporated and the crude reaction mixture was purified by means of 
column chromatography on silica gel (hexane/EtOAc 1/1). 
The hydroformylation of N-(2-methyl-2-propenyl)-β-lactams 3f-j was performed applying 
similar reaction conditions using Rh(acac)(CO)2 (substrate/Rh = 1000) and tris(2,4-di-tert-
butylphenyl)phosphite as a ligand (ligand/Rh = 10) in degassed toluene (cS = 0.25 M). The 
catalyst was preformed at 20 bar (CO/H2) and 100°C for 1 h at 2000 rpm, and 
hydroformylation took place at 20 bar (CO/H2) and 100°C for 16 h at 2000 rpm. 
cis-1-(4-Oxobutyl)-3-phenoxy-4-phenylazetidin-2-one 4a. Light-brown crystals. Mp 
79.5°C. Rf = 0.16 (hexane/EtOAc 1/1). 
1
H NMR (300 MHz, CDCl3): δ 1.65-1.88 (2H, m); 
2.47 (2H, t x d, J= 6.9, 3.9 Hz); 2.96 (1H, d x d x d, J= 14.2, 6.8, 6.7 Hz); 3.43 (1H, d x d x d, 
J= 14.2, 7.2, 7.2 Hz); 4.88 (1H, d, J= 4.4 Hz); 5.34 (1H, d, J= 4.4 Hz); 6.63-6.65, 6.77-6.82 
and 7.01-7.25 (10H, 3 x m); 9.69 (1H, s). 
13
C NMR (75 MHz, ref = CDCl3): δ 20.0; 40.1; 
41.5; 62.4; 81.9; 115.6; 122.1; 128.4; 128.7; 128.9; 129.3; 133.0; 156.9; 166.4; 201.2. IR 
(ATR, cm
-1
): νNC=O = 1750; νHC=O = 1716; νmax = 1492, 1240, 1089, 750, 688. MS (70eV): 
m/z (%) 310 (M
+
+1, 100). Anal. Calcd. for C19H19NO3: C 73.77, H 6.19, N 4.53. Found C 
73.58, H 6.37, N 4.32. 
 
Synthesis of N-(4-iminobutyl)-β-lactams 6a-f 
8 
General procedure. To a solution of aldehyde 4 (2.5 mmol) in dry CH2Cl2 (15 mL) was added 
anhydrous MgSO4 (5 mmol, 2 equiv) and the appropriate primary amine (2.5 mmol, 1 equiv), 
and the resulting suspension was stirred for one hour at room temperature. Afterwards, 
MgSO4 was removed through filtration and the solvent was evaporated under vacuum, 
affording the corresponding imine 6 in high purity (> 95% based on 
1
H NMR). Imines 6 were 
used as such in the next step due to their hydrolytic instability. 
cis-1-(4-Benzyliminobutyl)-3-phenoxy-4-phenylazetidin-2-one 6a. Yellow oil. 
1
H NMR 
(300 MHz, CDCl3): δ 1.78-1.89 (2H, m); 2.33 (2H, t x d, J= 7.6, 4.2 Hz); 3.01 (1H, d x d x d, 
J= 14.0, 6.9, 6.9 Hz); 3.56 (1H, d x d x d, J= 14.0, 7.3, 7.3 Hz); 4.54 (2H, s); 4.92 (1H, d, J= 
4.4 Hz); 5.37 (1H, d, J= 4.4 Hz); 6.68-6.71, 6.83-6.88 and 7.08-7.31 (15H, 3 x m); 7.78 (1H, t, 
J= 4.2 Hz). 
13
C NMR (75 MHz, ref = CDCl3): δ 23.7; 33.2; 40.2; 62.2; 65.0; 81.8; 115.6; 
122.0; 126.8; 127.2; 128.0; 128.3; 128.6; 128.7; 129.3; 133.3; 139.4; 157.0; 164.2; 166.0. IR 
(ATR, cm
-1
): νC=O = 1753; νC=N = 1666; νmax = 2922, 1494, 1234, 751, 734, 698. MS (70eV): 
m/z (%) 399 (M
+
+1, 100). 
 
Synthesis of N-[4-(2-oxoazetidin-1-yl)-but-1-enyl]acetamides 7a-f 
To a solution of imine 6 (2 mmol) and triethylamine (6 mmol, 3 equiv) in benzene (10 mL) 
was added dropwise a solution of alkoxyacetyl chloride (2.6 mmol, 1.3 equiv) in benzene (5 
mL) under reflux. After complete addition, the reaction mixture was stirred for 15 hours at 
room temperature. Subsequently, benzene was evaporated under reduced pressure and the 
reaction mixture was re-dissolved in dichloromethane (10 mL) and washed with water (10 
mL). After extracting the aqueous phase with dichloromethane (2 x 10 mL), the combined 
organic fractions were dried (MgSO4). Filtration of the drying agent and removal of the 
solvent afforded crude N-[4-(2-oxoazetidin-1-yl)-but-1-enyl]acetamide 7, which was purified 
by column chromatography on silica gel (hexane/EtOAc 1/1). Due to hindered rotation across 
the amido moiety, a major and minor isomer was observed upon spectroscopic analysis. 
N-Benzyl-2-methoxy-N-[4-(cis-2-oxo-3-phenoxy-4-phenylazetidin-1-yl)but-1-enyl]-
acetamide 7a. Light-yellow oil. Rf = 0.14 (hexane/EtOAc 1/1). 
1
H NMR (300 MHz, CDCl3): 
δ 2.11-2.34 (4H, m, major + minor); 2.94 (2H, d x d x d, J= 14.3, 6.9, 6.9 Hz, major + minor); 
3.41 (3H, s, minor); 3.49 (3H, s, major); 3.39-3.54 (2H, m, major + minor); 4.13 (2H, s, 
minor); 4.31 (2H, s, major); 4.63 (1H, d, J= 4.4 Hz, major); 4.72 (2H, s, minor); 4.80-4.97 
(5H, m, major + minor); 5.26 and 5.31 (2 x 1H, 2 x d, J= 4.4 Hz, major + minor); 6.60-6.73, 
6.85-6.90 and 7.10-7.36 (32H, 3 x m, major + minor). 
13
C NMR (75 MHz, ref = CDCl3): δ 
28.7; 40.4; 40.8; 46.7; 47.9; 59.4; 62.3; 62.8; 71.5; 71.8; 81.9; 109.0; 109.5; 115.6; 122.1; 
9 
125.6; 127.0; 127.3; 127.7; 127.9; 128.3; 128.6; 128.8; 129.3; 133.1; 136.9; 156.9; 166.1; 
168.1. IR (NaCl, cm
-1
): νC=O = 1752; νC=C = 1681; νmax = 2932, 1651, 1406, 1233, 1194, 752, 
736, 699. MS (70eV): m/z (%) 471 (M
+
+1, 100). Anal. Calcd. for C29H30N2O4: C 74.02, H 
6.43, N 5.95. Found C 73.83, H 6.61, N 5.68. 
 
Electronic Supplementary Information (ESI) available: spectroscopic data for compounds 4b-
j, 6b-f and 7b-f. 
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